The hyperinflammatory response in COVID-19 is characterized by elevated levels of serum TNF-α, IL-6, and to a lower level IL-1A since this cytokine has a short serum half-life (Del Valle et al., 2020). This evidence concerns the gene IL6 and COVID-19.